2011Unpublished venueRequires access

Effects of transcatheter arterial chemoembolization combined with or without radiotherapy on patients with advanced unresectable hepatocellular carcinoma

Xuecheng Zhang

Open publisher page 0 citations

Abstract

Objective:To evaluate effects of transcatheter arterial chemoembolization(TACE) combined with or without radiation therapy on patients with advanced unresectable hepatocellular carcinoma.Methods:From July 2005 to June 2008,116 patients with advanced unresectable hepatocellular carcinoma were divided into 2 groups,63 cases were treated with TACE(TACE group),53 cases,were treated with TACE and accelerator(Combined group),53 cases.For TACE,20 mg mitomycin C,1000-1500 mg 5-fluorouracil and 60-80 mg cisplatin were perfused into the hepatic arteries,10-20 mliodized oil was given to emobolized the hepatic arteries,and each patient was treated with 2-3 sessions.For combined group,10MV-X was used,≥95% isodose included PTV,and the total treatment doses was 40-60Gy,3-5 times per week.Average dose of liver 25Gy,V30Gy30%;Results:For TACE group and combined group,the 2 year local control rates were 30.2% and 43.6%,respectively.and 3year local control rates were 24.4%,37.9%,(P0.05).For TACE group,2 and 3 year survival rates were 30.1% and 21.5% respectively,and for combined group,they were 21.5% and 32.6% respectively.There was no significant differences for 2 year survival rates(P=0.056),but there was a statistically significant difference for 3 year survival rates(P=0.034).Combined group was found 2 case with radiation induced liver disease(RILD),TACE group was no one was found with RILD.Conclusion:The efficacy of TACE combined with radiotherapy was better than TACE alone for advanced unresectable hepatocellular carcinoma.The toxicity was similar,and clinically acceptable.

About this research paper

What this paper is about

Objective:To evaluate effects of transcatheter arterial chemoembolization(TACE) combined with or without radiation therapy on patients with advanced unresectable hepatocellular carcinoma.Methods:From July 2005 to June 2008,116 patients with advanced unresectable hepatocellular carcinoma were divided into 2 groups,63 cases were treated with TACE(TACE group),53 cases,were treated with TACE and accelerator(Combined group),53 cases.For TACE,20 mg mitomycin C,1000-1500 mg 5-fluorouracil and 60-80 mg cisplatin were perfused into the hepatic arteries,10-20 mliodized oil was given to emobolized the hepatic arteries,and each patient was treated with 2-3 sessions.For combined group,10MV-X was used,≥95% isodose included PTV,and the total treatment doses was 40-60Gy,3-5 times per week.Average dose of liver 25Gy,V30Gy30%;Results:For TACE group and combined group,the 2 year local control rates were 30.2% and 43.6%,respectively.and 3year local control rates were 24.4%,37.9%,(P0.05).For TACE group,2 and 3 year survival rates were 30.1% and 21.5% respectively,and for combined group,they were 21.5% and 32.6% respectively.There was no significant differences for 2 year survival rates(P=0.056),but there was a statistically significant difference for 3 year survival rates(P=0.034).Combined group was found 2 case with radiation induced liver disease(RILD),TACE group was no one was found with RILD.Conclusion:The efficacy of TACE combined with radiotherapy was better than TACE alone for advanced unresectable hepatocellular carcinoma.The toxicity was similar,and clinically acceptable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate effects of transcatheter arterial chemoembolization(TACE) combined with or without radiation therapy on patients with advanced unresectable hepatocellular carcinoma.Methods:From July 2005 to June 2008,116 patients with advanced unresectable hepatocellular carcinoma were divided into 2 groups,63 cases were treated with TACE(TACE group),53 cases,were treated with TACE and accelerator(Combined group),53 cases.For TACE,20 mg mitomycin C,1000-1500 mg 5-fluorouracil and 60-80 mg cisplatin were perfused into the hepatic arteries,10-20 mliodized oil was given to emobolized the hepatic arteries,and each patient was treated with 2-3 sessions.For combined group,10MV-X was used,≥95% isodose included PTV,and the total treatment doses was 40-60Gy,3-5 times per week.Average dose of liver 25Gy,V30Gy30%;Results:For TACE group and combined group,the 2 year local control rates were 30.2% and 43.6%,respectively.and 3year local control rates were 24.4%,37.9%,(P0.05).For TACE group,2 and 3 year survival rates were 30.1% and 21.5% respectively,and for combined group,they were 21.5% and 32.6% respectively.There was no significant differences for 2 year survival rates(P=0.056),but there was a statistically significant difference for 3 year survival rates(P=0.034).Combined group was found 2 case with radiation induced liver disease(RILD),TACE group was no one was found with RILD.Conclusion:The efficacy of TACE combined with radiotherapy was better than TACE alone for advanced unresectable hepatocellular carcinoma.The toxicity was similar,and clinically acceptable.

Key concepts: Medicine, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Radiation therapy, Gastroenterology, Internal medicine, Survival rate, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of transcatheter arterial chemoembolization combined with or without radiotherapy on patients with advanced unresectable hepatocellular carcinoma — Research Paper | ScholarLens